Dr Angela Young
Dr Angela Young
Contact
Phone
show phone number
Dr Angela Young is a Clinical Trials Program Manager and the Allergy Flagship Program Manager at the Murdoch Children's Research Institute (MCRI); and Programs and Partnerships Manager of the National Allergy Centre of Excellence (NACE).
Dr Young’s academic research expertise in child health allergy and immunology contribute to MCRI’s impact in food allergy prevention, diagnosis and management.
She helps oversee the start-up and operation of a number of sponsored and investigator-led trials within the Population Allergy Group that are undertaken with the support of the Melbourne Children’s Trials Centre. As Senior Coordinator of the VITALITY Trial, Dr Young helped facilitate the enrolment of almost 3000 babies to investigate the relationship between food allergy, vitamin D and immune function in infants.
The MCRI Allergy Flagship research programs aim to increase the translation of clinical research into practice. Dr Young helps drive collaboration for research and increase capacity across the Melbourne Children’s Campus.
In 2022, the NACE launched thanks to a $10.2 million Federal Government investment. It will deliver a national plan of action to accelerate research across drug, food, insect, and respiratory allergic disease. Dr Young supports the NACE Director, A/Prof Kirsten Perrett, to coordinate the development and implementation of the NACE research priorities and strategy in consultation with key stakeholders.
As a laboratory-based scientist, Dr Young’s early career began in cellular immunology and investigating the mechanisms of allergic disease. She joined the Telethon Kids Institute in 2001 as a Research Assistant and PhD Candidate. Her PhD thesis, in conjunction with the University of Western Australia, was titled 'Epithelial cell regulation of dendritic cell maturation in the airway mucosa: studies in an in vitro model system'. This was supported by an NHMRC post-graduate scholarship and top-up scholarships from the Asthma Foundation of WA and the Stan and Jean Perron Trust.
In 2009, Dr Young moved into data linkage with the Population Health Research Network before returning to investigating allergy in a clinical-trial based setting at MCRI in 2019.
Dr Young’s academic research expertise in child health allergy and immunology contribute to MCRI’s impact in food allergy prevention, diagnosis and management.
She helps oversee the start-up and operation of a number of sponsored and investigator-led trials within the Population Allergy Group that are undertaken with the support of the Melbourne Children’s Trials Centre. As Senior Coordinator of the VITALITY Trial, Dr Young helped facilitate the enrolment of almost 3000 babies to investigate the relationship between food allergy, vitamin D and immune function in infants.
The MCRI Allergy Flagship research programs aim to increase the translation of clinical research into practice. Dr Young helps drive collaboration for research and increase capacity across the Melbourne Children’s Campus.
In 2022, the NACE launched thanks to a $10.2 million Federal Government investment. It will deliver a national plan of action to accelerate research across drug, food, insect, and respiratory allergic disease. Dr Young supports the NACE Director, A/Prof Kirsten Perrett, to coordinate the development and implementation of the NACE research priorities and strategy in consultation with key stakeholders.
As a laboratory-based scientist, Dr Young’s early career began in cellular immunology and investigating the mechanisms of allergic disease. She joined the Telethon Kids Institute in 2001 as a Research Assistant and PhD Candidate. Her PhD thesis, in conjunction with the University of Western Australia, was titled 'Epithelial cell regulation of dendritic cell maturation in the airway mucosa: studies in an in vitro model system'. This was supported by an NHMRC post-graduate scholarship and top-up scholarships from the Asthma Foundation of WA and the Stan and Jean Perron Trust.
In 2009, Dr Young moved into data linkage with the Population Health Research Network before returning to investigating allergy in a clinical-trial based setting at MCRI in 2019.
Dr Angela Young is a Clinical Trials Program Manager and the Allergy Flagship Program Manager at the Murdoch Children's Research Institute (MCRI); and Programs and Partnerships Manager of the National Allergy Centre of Excellence (NACE).
Dr Young’s...
Dr Young’s...
Dr Angela Young is a Clinical Trials Program Manager and the Allergy Flagship Program Manager at the Murdoch Children's Research Institute (MCRI); and Programs and Partnerships Manager of the National Allergy Centre of Excellence (NACE).
Dr Young’s academic research expertise in child health allergy and immunology contribute to MCRI’s impact in food allergy prevention, diagnosis and management.
She helps oversee the start-up and operation of a number of sponsored and investigator-led trials within the Population Allergy Group that are undertaken with the support of the Melbourne Children’s Trials Centre. As Senior Coordinator of the VITALITY Trial, Dr Young helped facilitate the enrolment of almost 3000 babies to investigate the relationship between food allergy, vitamin D and immune function in infants.
The MCRI Allergy Flagship research programs aim to increase the translation of clinical research into practice. Dr Young helps drive collaboration for research and increase capacity across the Melbourne Children’s Campus.
In 2022, the NACE launched thanks to a $10.2 million Federal Government investment. It will deliver a national plan of action to accelerate research across drug, food, insect, and respiratory allergic disease. Dr Young supports the NACE Director, A/Prof Kirsten Perrett, to coordinate the development and implementation of the NACE research priorities and strategy in consultation with key stakeholders.
As a laboratory-based scientist, Dr Young’s early career began in cellular immunology and investigating the mechanisms of allergic disease. She joined the Telethon Kids Institute in 2001 as a Research Assistant and PhD Candidate. Her PhD thesis, in conjunction with the University of Western Australia, was titled 'Epithelial cell regulation of dendritic cell maturation in the airway mucosa: studies in an in vitro model system'. This was supported by an NHMRC post-graduate scholarship and top-up scholarships from the Asthma Foundation of WA and the Stan and Jean Perron Trust.
In 2009, Dr Young moved into data linkage with the Population Health Research Network before returning to investigating allergy in a clinical-trial based setting at MCRI in 2019.
Dr Young’s academic research expertise in child health allergy and immunology contribute to MCRI’s impact in food allergy prevention, diagnosis and management.
She helps oversee the start-up and operation of a number of sponsored and investigator-led trials within the Population Allergy Group that are undertaken with the support of the Melbourne Children’s Trials Centre. As Senior Coordinator of the VITALITY Trial, Dr Young helped facilitate the enrolment of almost 3000 babies to investigate the relationship between food allergy, vitamin D and immune function in infants.
The MCRI Allergy Flagship research programs aim to increase the translation of clinical research into practice. Dr Young helps drive collaboration for research and increase capacity across the Melbourne Children’s Campus.
In 2022, the NACE launched thanks to a $10.2 million Federal Government investment. It will deliver a national plan of action to accelerate research across drug, food, insect, and respiratory allergic disease. Dr Young supports the NACE Director, A/Prof Kirsten Perrett, to coordinate the development and implementation of the NACE research priorities and strategy in consultation with key stakeholders.
As a laboratory-based scientist, Dr Young’s early career began in cellular immunology and investigating the mechanisms of allergic disease. She joined the Telethon Kids Institute in 2001 as a Research Assistant and PhD Candidate. Her PhD thesis, in conjunction with the University of Western Australia, was titled 'Epithelial cell regulation of dendritic cell maturation in the airway mucosa: studies in an in vitro model system'. This was supported by an NHMRC post-graduate scholarship and top-up scholarships from the Asthma Foundation of WA and the Stan and Jean Perron Trust.
In 2009, Dr Young moved into data linkage with the Population Health Research Network before returning to investigating allergy in a clinical-trial based setting at MCRI in 2019.
Career information
Share //
